• 제목/요약/키워드: platinum

검색결과 1,167건 처리시간 0.029초

자동차(自動車) 폐촉매(廢觸媒)의 침출액(浸出液)으로부터 백금족(白金族) 금속(金屬)의 용매추출(溶媒抽出) (Solvent Extraction of Platinum Group Metals from the leach Liquor of Spent Automotive Catalyst)

  • 김미애;이재천;김치권;김민석;김병수;유경권
    • 자원리싸이클링
    • /
    • 제15권5호
    • /
    • pp.3-10
    • /
    • 2006
  • 자동차 폐촉매의 침출액으로부터 백금족 금속의 분리를 위하여 용매추출에 대한 기초연구가 수행되었다. 추출제로 tri-n-butyl phosphate (TBP), tri-n-octylamine (TOA) 그리고 di-n-hexyl sulfide (DHS)를 등유에 희석하여 사용하였다. 추출제의 종류 및 농도가 백금, 팔라듐 그리고 로듐의 추출거동에 미치는 영향을 조사하였다. 또한 세륨, 납, 철, 마그네슘 그리고 알루미늄 등 침출액에 존재하는 주요 금속불순물의 추출거동도 함께 조사하였다. TBP는 백금과 팔라듐, 그리고 TOA는 백금, 팔라듐, 로듐을 동시에 추출하였다. DHS 추출제인 SFI-6에 의한 용매추출 시 백금이 팔라듐과 함께 유기상으로 추출되었으나, SFI-6R은 팔라듐만 선택적으로 추출하였다. SFI-6R은 SFI-6에 비하여 팔라듐에 대한 선택성이 우수하였으나 추출속도가 느렸다. 추출제의 종류에 따라 백금족 금속과 함께 추출되는 금속불순물들이 달라지며 세정 또는 탈거공정에서 이들을 제거하여야 한다. 자동차 폐촉매의 침출액으로부터 백금, 팔라듐 그리고 로듐을 분리하기 위하여 먼저 DHS 추출제인 SFI-6R를 사용하여 팔라듐을 분리한 다음 TBP 또는 TOA으로 백금을 추출하여 로듐과 분리하는 공정이 적절한 것으로 나타났다.

백금 나노입자 전착의 전기화학적 분석 (Electrochemical Analysis of the Electrodeposition of Platinum Nanoparticles)

  • 이혜민;조성운;김준현;김창구
    • Korean Chemical Engineering Research
    • /
    • 제53권5호
    • /
    • pp.540-544
    • /
    • 2015
  • 나노입자를 기판 위에 직접 부착시키는 방법인 전착(electrodeposition)을 이용하여 저가의 그라파이트(graphite) 기판 위에 백금 나노입자를 직접 부착시킬 수 있는 전착 욕(bath)을 개발하였고, 백금 나노입자 전착반응의 전기화학적인 특성을 분석하였다. 백금 나노입자 전착의 분극 거동 분석을 통하여 반응메카니즘을 파악하였고, 순환전위측정(cyclic voltammetry)을 통하여 백금 나노입자 전착에서는 물질전달이 속도결정단계임을 확인하였다. 또한 시간대전류법(chronoamperometry)으로 분석한 백금 나노입자 전착의 전류밀도 변화 양상은 백금 나노입자의 결정핵 생성 메카니즘이 instantaneous로 판명되었다. 그라파이트는 다른 탄소계열 기판에 비하여 매우 저가이기 때문에 그라파이트 기판 위에 백금 나노입자를 직접 부착시키는 기술은 산업적으로 유용할 것으로 기대한다.

새로운 백금 착체(II) 화합물의 흰쥐 혈장에서 대사체 확인 (Identification of Major Metabolites of New Platinum(II) Complexes in Rats)

  • 김종환;조요나;노영수;서성훈;정지창;장성구;이규홍;이주한;이경태
    • Journal of Pharmaceutical Investigation
    • /
    • 제28권3호
    • /
    • pp.171-175
    • /
    • 1998
  • KHPC-002 $[(trans-l-diaminocyclohexane-bis-l,2(diphenylphosphinoethane)platinum)\;{\cdot}2NO_3]$ and $KHPC-006[(cis-diaminocyclohexane-bis-1,2(diphenylphosphinoethane)platinum)\;{\cdot}2NO_3]$ were synthesized as candidates for third platinum antitumor agent. Before their pharmacokinetic study, we optimized the analytical condition with HPLC and identified the major metabolites in the rat plasma. HPLC analysis by $C_{18}$ reverse-phase column showed that standard peak of both compounds appeared rapidly at around 1 minutes, whereas metabolites of KHPC-002 and KHPC-006 which were extracted from plasma after single I.V. administration in rats or incubation for 24 hr at $37^{\circ}C$ showed retention time of $10{\sim}11$ minutes. These metabolites were identified as the major compound by Matrix Associated Laser Deposition/Ionization (MALDI), which only lose the 2 molecules of $NO_3$. Based on these results, we suggest that the major metabolites of KHPC-002 and KHPC-006 were [trans-l-diamino-cyclohexane-bis-l,2(diphenylphosphinoethane)platinum] and [cis-diaminocyclohexane-bis-l.2(diphenylphosphinoethane)platinum], respectively.

  • PDF

비피리미딘계 배위자를 골격으로 하는 Pt(II)착체의 합성 및 특성 (A Synthesis and Characterization of Pt(II) Complexes with Bipyrimidin-based Back-bone System)

  • 손석환;안호근;정민철
    • Korean Chemical Engineering Research
    • /
    • 제54권4호
    • /
    • pp.555-559
    • /
    • 2016
  • 본 연구에서는 2,2'-bispyrimidine (bpim), 2,2'-bipyridine (bpy), 5,5'-dimethyl-2,2'-bipyridine (5,5-mebpy), 5'-bromo-2,2'-bipyridine (5-brbpy), 5,5'-dibromo-2,2'-bipyridine (5,5-brbpy), 4,4'-dimethyl-2,2'-bipyridine (4,4-mebpy), 4,4'-dihexyl-2,2'-Bipyridine (4,4-hebpy), 1,10'-Phenanthroline (phen), 3,4,7,8'-tetramethyl-1,10'-Phenanthroline (3,4,7,8-phen)을 사용하여 단핵 Platinum착체를 합성하였다. 합성되어진 Platinum착체의 화학적 구조를 결정하기 위해서 $^1H(^{13}C)$-NMR, FT-IR을 사용하였으며, 광 물리학적 특성에 대한 측정은 UV-vis, PL을 통하여 측정하였다. 합성한 Platinum착체는 356 nm~421 nm영역에서 발광파장이 확인되었으며, DMSO용액에서 내부양자효율이 0.05~0.46으로 나타났다.

신규 백금착물 항암제 KBP31705-C127, KBP30603-901의 Cisplatin 및 Carboplatin과의 약동력학적 동태 비교 (Comparisons in Pharmacokinetic Profiles of New Platinum Coordination Complexes, KBP31705-C127 and KBP30603-901 with Cisplatin and Carboplatin)

  • 정인숙;이주선;허수정;김진숙;진창배;김동현;김명배;박경수;손연수
    • Biomolecules & Therapeutics
    • /
    • 제4권4호
    • /
    • pp.349-353
    • /
    • 1996
  • The present study examined pharmacokinetic profiles of KBP31705-Cl27 and KBP30603-901, new platinum coordination complexes synthesized as anticancer candidates, in comparison with two well-known platinum-containing anticancer agents, cisplatin and carboplatin in rats. Under sodium pentobarbital anesthesia of male Sprague-Dawley rats, urinary bladder, and femoral artery and vein were catheterized for urine collection, blood sampling and drug injection, respectively Following i.v. administration of cisplatin (2 mg/kg), KBP31705-C127 (2 mg/kg), carboplatin (20 mg/kg) or KBP30603-901 (20 mg/kg), blood samples were collected at 2, 4, 6, 8, 10, 15, 20, 30, 45, 60 and 120 minutes. Urine samples were collected at 1-hr interval for 4 hr. Platinum concentrations in plasma and urine were measured using an inductively coupled plasmamass spectrometer. The plasma concentration-time curves were biphasic for all drugs during the time period studied. Compared with cisplatin, KBP31705-C127 showed similar decay patters in the alpha- and betaphases with slightly lower plasma concentrations. Urinary platinum excretion for cisplatin and KBP31705-C 127 was 56 and 52% of the administered dose in 4 hr, respectively. With regard to carboplatin and KBP 30603-901, a similar decay pattern was also observed in the alpha-phase. The half life of KBP30603-901 in the beta-phase, however, was much longer than that of carboplatin, which was consistent with the urinary excretion results that 46 and 59% of the administered dose were excreted in the urine in 4hr, respectively. The results suggest that platinum coordination complexes are primarily excreted via the renal route and KBP30603-901 can elicit longer duration of action due to slower renal excretion compared to carboplatin.

  • PDF

In Vitro Cytotoxicity of Novel Platinum(II) Coordination Complexes Containing Diaminocyclohexane and Diphenylphosphines

  • Jung, Jee-Chang;Kim, Young-Kyu;Park, Seung-Joon;Chung, Joo-Ho;Chang, Sung-Goo;Lee, Kyung-Tae;Baek, Min-Son;Park, Jong-Jip;Rho, Young-Soo
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제2권3호
    • /
    • pp.395-401
    • /
    • 1998
  • We have synthesized new platinum(II) analogs containing 1,2-diaminocyclohexane (dach) as a carrier ligand, 1,3-bis(diphenylphosphino) propane (DPPP) /1,2-bis(diphenylphosphino)ethane (DPPE) as a leaving group and nitrates to improve solubility. In the present study, the cytotoxicity of $[Pt(trans-l-dach)(DPPP)]\;2NO_3$ (KHPC-001) and $[Pt(trans-l-dach)(DPPE)]\;2NO_3$ (KHPC-002) was evaluated and compared on various P-388 cancer cell lines and porcine kidney cell line ($LLC-PK_1$). The new platinum complexes demonstrated high efficacy on P-388 mouse leukemia cell line as well as cisplatin-resistant (P-388/CDDP) and adriamycin-resistant (P-388/ADR) P-388 cell lines. The intracellular platinum content was measured by a flame atomic absorption spectrophotometer (FAAS), and it was comparable to the results of $IC_{50}$ of the three complexes on $LLC-PK_1$ and P-388/S cells, while only DPPE compound was accumulated in high volume in P-388/ADR and P-388/CDDP cells. While the DNA-interstrand cross-links of KHPC-001, KHPC-002 and cisplatin were similar on P-388/S leukemia cells, these new platinum complexes were much less DNA cross-linking to a kidney derived cell line, $LLC-PK_1$. These results indicate that KHPC-001 and KHPC-002 are a third-generation platinum complexes with potent antitumor activity and low nephrotoxicity.

  • PDF

Upper eyelid platinum weight placement for the treatment of paralytic lagophthalmos: A new plane between the inner septum and the levator aponeurosis

  • Oh, Tae Suk;Min, Kyunghyun;Song, Sin Young;Choi, Jong Woo;Koh, Kyung Suk
    • Archives of Plastic Surgery
    • /
    • 제45권3호
    • /
    • pp.222-228
    • /
    • 2018
  • Background The most common surgical treatment for paralytic lagophthalmos is the placement of a weight implant in the upper eyelid; however, this technique confers the risks of implant visibility, implant extrusion, and entropion. In this study, we present a new technique of placing platinum weight implants between the levator aponeurosis and inner septum to decrease such complications. Methods A total of 37 patients with paralytic lagophthalmos were treated between March 2014 and January 2017 with platinum weight placement (mean follow-up, 520.1 days). After dissecting through the orbicularis oculi muscle, the tarsal plate and levator aponeurosis were exposed. The platinum weights (1.0-1.4 g) were fixed to the upper margin of the tarsal plate and placed underneath the orbital septum. Results Five patients could partially close their eye after surgery. The average distance between the upper eyelid and the lower eyelid when the eyes were closed was 1.12 mm. The rest of the patients were able to close their eye completely. Three patients patient developed allergic conjunctivitis after platinum weight insertion, which was managed with medication. None of the patients complained of discomfort in the upper eyelid after surgery. Visibility or extrusion of the implant were observed in three patients. Conclusions Postseptal weight placement is a safe and reproducible method in both primary and secondary upper eyelid surgery for patients with paralytic lagophthalmos. It is a feasible method for preventing implant visibility, implant exposure, and entropion. Moreover, platinum is a better implant material than gold because of its smaller size and greater thinness.

Effectiveness and Technical Considerations of Solitaire Platinum 4×40 mm Stent Retriever in Mechanical Thrombectomy with Solumbra Technique

  • Yi, Ho Jun;Sung, Jae Hoon;Lee, Dong Hoon;Song, Seung Yoon
    • Journal of Korean Neurosurgical Society
    • /
    • 제64권1호
    • /
    • pp.30-38
    • /
    • 2021
  • Objective : The Solitaire Platinum 4×40 mm stent retriever contains radiopaque markers with a long length. We evaluated the effect of Solitaire Platinum 4×40 mm stent retriever in Solumbra technique thrombectomy, and compared it with shorter Solitaire stent retrievers. Methods : A total of 70 patients who underwent Solumbra technique thrombectomy with equal diameter (4 mm) and different length (40 vs. 20 mm) Solitaire stent retrievers were divided into two groups : the Solitaire Platinum 4×40 mm stent (4×40) group and the Solitaire FR 4×20 mm stent or Solitaire Platinum 4×20 mm stent (4×20) group. The clinical outcomes, Thrombolysis in Cerebral Infarction score, the first pass reperfusion status, and complications were evaluated and compared between the two groups. Multivariate analysis was performed to evaluate the predictive factors for reperfusion and complete reperfusion from the first pass. Results : Higher first-pass reperfusion and complete reperfusion were achieved in the 4×40 group (68.0% and 48.0%) than in the 4×20 group (46.7% and 33.3%; p=0.004 and 0.007, respectively). In multivariate analysis, radiopaque device and longer stent retriever were correlated with first-pass reperfusion (p=0.014 and 0.008, respectively) and first-pass complete reperfusion (p=0.022 and 0.012, respectively). Conclusion : Our study demonstrated the usefulness of the Solitaire Platinum 4×40 mm stent retriever, which led to higher first-pass reperfusion and complete reperfusion rates than the Solitaire FR 4×20 mm stent or the Solitaire Platinum 4×20 mm stent, especially in Solumbra technique thrombectomy.

염산용액에서 하이드라진에 의한 백금과 팔라듐의 환원석출 (Reductive Precipitation of Platinum and Palladium with Hydrazine in Hydrochloric Acid Solution)

  • 김민석;김병수;유재민;유경근;이재천;김원백
    • 대한금속재료학회지
    • /
    • 제46권4호
    • /
    • pp.233-240
    • /
    • 2008
  • The reductive precipitation of platinum and palladium in hydrochloric acid solution using hydrazine as a reducing agent was investigated. The reductive precipitation ratios of platinum and palladium increased when increasing the stoichiometric ratio for reducing agent, precipitation time, and pH. The precipitation ratio of platinum was much lower than that of palladium. This is the reason the reaction rate of $PtCl{_6}^{2-}{\rightarrow}PtCl{_4}^{2-}$ at the reduction reaction step of $PtCl{_6}^{2-}{\rightarrow}PtCl{_4}^{2-}{\rightarrow}Pt$ is very slow. The purity of platinum precipitated was very affected by metallic impurities, while it was possible to precipitate the high purity palladium since the precipitation rate of palladium was relatively fast. At the pH of 1.3, the precipitation temperature of $25^{\circ}C$, and the addition amounts of the hydrazine of 10 and 1.75 times the stoichiometric ratio, the reductive precipitation ratios of platinum and palladium from their hydrochloric acid solutions containing 2,000 ppm were 98.5% and 99.9% in 30 min, respectively.

석유 폐촉매로부터 백금 회수를 위한 담체의 황산용해 (Sulfuric Acid Dissolution of Carriers for Recovering Platinum from the Spent Petroleum Catalysts)

  • 이재천;정진기;김병수;김민석;조영수
    • 자원리싸이클링
    • /
    • 제13권1호
    • /
    • pp.14-21
    • /
    • 2004
  • 백금을 함유하고 있는 폐촉매가 정유공장과 화학공장에서 발생하고 있다. 백금은 고가일 뿐만 아니라 희귀하고 뛰어난 물성으로 인하여 오래 전부터 회수대상이 되어 왔다. 본 연구에서는 알루미나로 구성된 폐촉매의 담체를 황산으로 용해하여 불용성 백금을 농축하는 방법으로 석유 폐촉매로부터 백금을 회수하고자 하였다. 황산에 일부 용해된 백금은 알루미늄을 환원제로 사용하는 세멘테 이션법으로 회수되었다. 온도, 시간, 황산농도, 광액농도 등이 담체의 용해에 미치는 영향을 조사하였다. 담체가 $\Upsilon-Al_2$$O_3$로 구성된 폐 촉매를 6.0 M $H_2$$SO_4$ 용액으로 $100^{\circ}C$에서 2시간 동안 용해하였을 때 알루미나의 용해율은 약 95% 정도이었다. 담체가 $\Upsilon-Al_2$O$_3$$\alpha$-$Al_2$O$_3$의 혼합물로 구성되어 있는 경우, 4시간 용해하였을 때 약 92%의 알루미나가 용해하였다. 담체를 황산으로 용해한 다음 백금을 회수하는 방법을 이용하여 석유 폐촉매로부터 99% 이상의 백금을 회수할 수 있었으며 동시에 황산알루미늄을 부산물로 얻었다.